/

Empresas

En

No verificado

Enveda

Sobre qué escribimos

BiotecnologíaCienciaFarmacéuticaSaludTécnica

12 Comunicados de prensa

Ver todos los comunicados de prensa

15/04/2026

Mercado laboral

Salud

Técnica

Ciencia

Farmacéutica

Biotecnología

Enveda Appoints Christopher K. Porter, MBA, JD as Senior Vice President, Clinical Operations

Fuente

Editor

1.00

0

31/03/2026

Enveda Reports Positive Results for ENV-294 in a Phase 1b Clinical Trial of Patients with Moderate-to-Severe Atopic Dermatitis

Fuente

Editor

1.00

0

23/12/2025

Ciencia

Técnica

Higiene alimentaria

Medicina - Varios

Biotecnología

Farmacéutica

Salud

Industria

Enveda Advances Third Asset to the Clinic With US FDA IND Clearance and Phase 1 Initiation of ENV-6946, a First-in-Class Oral “Multi-Biologic in a Pill” for Inflammatory Bowel Disease

Fuente

Editor

1.00

0

17/12/2025

Mercado laboral

Industria

Ciencia

Técnica

Higiene alimentaria

Medicina - Varios

Biotecnología

Farmacéutica

Salud

Enveda Announces US FDA IND Clearance and First Patient Dosed in Phase 1 Trial of ENV-308, a First-in-Class Oral Therapy for Obesity; Appoints Nadeem Sarwar, Ph.D., MPharm, MPhil, to Lead Metabolic Disease Strategy

Fuente

Editor

1.00

0

09/12/2025

Industria

Higiene alimentaria

Tecnología de la información

Técnica

Farmacéutica

Sanidad

Biotecnología

Medicina - Varios

Ciencia

Software

Salud

Enveda Initiates Phase 2 Clinical Trials of ENV-294, a First-in-Class Oral Therapy in Atopic Dermatitis and Asthma

Fuente

Editor

1.00

0

04/09/2025

Enveda Raises $150M Series D Funding to Reach Unicorn Status, Enrolls First Patient in Lead Program, and Adds Mikael Dolsten to Board of Directors

Fuente

Editor

1.00

0

28/05/2025

Técnica

Biotecnología

Salud

Sanidad

Farmacéutica

Ciencia

Tecnología

Software

Medicina - Varios

Industria

Enveda Reports Favorable Phase 1 Safety for Novel Oral Anti-Inflammatory, Launches Phase 1b Trial in Atopic Dermatitis

Fuente

Editor

1.00

0

26/02/2025

Ciencia

Técnica

Medicina - Varios

Biotecnología

Farmacéutica

Salud

Enveda Gains Backing from Sanofi to Advance AI-Driven Drug Discovery to Clinical Trials Bringing Total Series C Financing to $150M

Fuente

Editor

1.00

0

05/02/2025

Ciencia

Biotecnología

Farmacéutica

Salud

Técnica

Medicina - Varios

Mercado laboral

Industria

Enveda Expands into Asthma with First-in-Class Lead Asset ENV-294 and Assembles World-Class Advisory Board

Fuente

Editor

1.00

0

10/01/2025

Enveda Welcomes Jason Kim as Chief Financial Officer

Fuente

Editor

1.00

0

Seguidores

0

Compatibilidad

0